Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AstraZeneca
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histological confirmation of evidence of squamous cell carcinoma of the head and neck.
Tumors have progressed after primary treatment with radiation or chemoradiation and have failed to respond to at least one course of standard platinum-based chemotherapy.
Tumors have progressed after primary treatment with radiation or chemoradiation and are considered unsuitable for platinum-based chemotherapy.
You may not be if
Carcinomas of the post-nasal space, thyroid, sinus or salivary gland tumors.
Isolated recurrent disease that may be amenable to local therapy; e.g., surgical intervention or radiation therapy.
Known severe hypersensitivity to ZD1839, Methotrexate or any of the excipients of these products.
Clareo Health | Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX)
